BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 514 | Download: 1152
Publication Name World Journal of Gastroenterology
Manuscript ID 4464
Country/Territory Japan
Received
2013-07-01 10:32
Peer-Review Started
2013-07-02 09:07
To Make the First Decision
2013-08-08 11:33
Return for Revision
2013-08-08 16:01
Revised
2013-08-24 12:11
Second Decision
2013-09-03 14:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-04 07:24
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-10-15 17:18
Publish the Manuscript Online
2013-11-13 08:37
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Meta-Analysis
Article Title Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Manuscript Source Invited Manuscript
All Author List Yan-Yan Ma, Lin Li, Chao-Hui Yu, Zhe Shen, Li-Hua Chen and You-Ming Li
Funding Agency and Grant Number
Corresponding Author You-Ming Li, MD, Department of Gastroenterology, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. zlym@zju.edu.cn
Key Words Probiotics; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver function; Insulin resistance; Meta-analysis
Core Tip For many decades, researchers have carried out studies on the treatment of nonalcoholic fatty liver disease (NAFLD). However, no firm conclusions have been made regarding the efficacy of various treatments for NAFLD. Here we conducted a meta-analysis of the pooled data from randomized controlled trials to assess the efficacy of probiotic therapies and showed that probiotic therapy signi铿乧antly decreased alanine aminotransferase, aspartate transaminase, total-cholesterol, high density lipoprotein, tumor necrosis factor-飦?and homeostasis model assessment of insulin resistance. Thus, probiotics may help to improve liver function, fat metabolism and insulin resistance in NAFLD patients.
Publish Date 2013-11-13 08:37
Citation Shimoyama S. Diabetes mellitus carries a risk of gastric cancer: A meta-analysis. World J Gastroenterol 2013; 19(40): 6902-6910
URL http://www.wjgnet.com/1007-9327/full/v19/i40/6902.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i40.6902
Manuscript File 4464-Review.doc
Answering Reviewers 4464-Answering reviewers.pdf
Copyright License Agreement 4464-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4464-Language certificate.pdf
Peer-review Report 4464-Peer review(s).pdf
Scientific Editor Work List 4464-Scientific editor work list.doc